ROR
Os receptores órfãos relacionados ao ácido retinoico (RORs) são receptores nucleares que regulam vários processos fisiológicos, incluindo ritmo circadiano, resposta imune e metabolismo. Inibidores de RORs são de grande interesse no estudo de doenças autoimunes, distúrbios metabólicos e câncer, pois podem modular a expressão gênica e influenciar as funções celulares. Na CymitQuimica, oferecemos inibidores de RORs para apoiar sua pesquisa em imunologia, endocrinologia e oncologia.
Foram encontrados 47 produtos de "ROR"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
XY039
XY039 (compound 13e) is an RORγ inverse agonist with an IC50 value of 0.55 μM. XY039 induces cell apoptosis and exhibits antiproliferative activity both in vivo and in vitro.Fórmula:C23H19F5N2O4S2Peso molecular:546.07064RORγt inverse agonist 31
RORγt inverse agonist 31 (14g) is a potent antagonist of the retinoic acid receptor-related orphan receptor γt (RORγt), exhibiting an inhibitory concentration (Fórmula:C23H15Cl2F3N4O3SPureza:98%Cor e Forma:SolidPeso molecular:555.36RORγ antagonist 1
RORγ antagonist 1 (compound 22), a potent derivative of betulinic acid, acts as an antagonist to RORγ with a dissociation constant (K D) of 0.18 μM.Fórmula:C35H60N2O2Pureza:98%Cor e Forma:SolidPeso molecular:540.86Bevurogant
CAS:Bevurogant is an antagonist of RORγt receptor and can be used in studies about the treatment of chronic inflammatory diseases.Fórmula:C26H28N8O3SPureza:99.32%Cor e Forma:SolidPeso molecular:532.62RORγt inverse agonist 33
RORγt inverse agonist 33 (compound (R)-D4) is an orally bioavailable RORγt inverse agonist with an IC50 of 21 nM, playing a significant role in rheumatoid arthritis research.Fórmula:C27H37NO5SCor e Forma:SolidPeso molecular:487.651ROR1-IN-2
ROR1-IN-2 (compound 9I) is a potent and selective inhibitor of ROR1. It exhibits antiproliferative activity in various cancer cell lines and significantly inhibits tumor growth in vivo.Fórmula:C30H27N3O4Cor e Forma:SolidPeso molecular:493.20016RORγ agonist 2
RORγ agonist2 (Compound 34) is a selective RORγ agonist with an EC50 of 0.03 μM for hRORγ. It significantly inhibits tumor growth in an MC38 tumor mouse model with the same genetic background.Cor e Forma:Odour SolidTMP-778
CAS:TMP-778 is a selective inverse agonist of RORγt.Fórmula:C31H30N2O4Pureza:99.68%Cor e Forma:SolidPeso molecular:494.58ROR1 ligand-1
ROR1ligand-1 (9-1) serves as the ligand for PROTAC ROR1 degrader-1. By linking with ligands of either the VHL type or CRBN, the first selective and efficient ROR1 PROTAC molecule was designed and synthesized.Fórmula:C23H30BrN7Cor e Forma:SolidPeso molecular:484.44Antitumor agent-127
Antitumor agent-127 (compound 1) is a parent macrocyclic peptide that demonstrates nanomolar binding affinity to ROR1 and shows relatively good internalization in 786-O and MDA-MB-231 tumor cell lines.Fórmula:C86H107N15O18SPeso molecular:1669.76392XY018
CAS:XY018 is a ROR-γ antagonist with anti-tumor activity, inhibits ROR-γ activity, and can be used to study drug-resistant prostate cancer.Fórmula:C23H15F7N2O4Pureza:99.95% - 99.96%Cor e Forma:SolidPeso molecular:516.37TMP920
CAS:TMP920 inhibits RORγt binding to the SRC1 peptide (IC50: 0.03 μM). TMP920 is a highly potent and selective RORγt antagonist.Fórmula:C29H30N2O3Pureza:98%Cor e Forma:SolidPeso molecular:454.56Neoruscogenin
CAS:1. Neoruscogenin represents a universal pharmacological tool for RORα research due to its specific selectivity profile versus other nuclear receptors.Fórmula:C27H40O4Pureza:99.5% - 99.92%Cor e Forma:SolidPeso molecular:428.60GSK805
CAS:GSK805 is a potent, orally bioavailable and CNS-penetrant RORγt inhibitor.Cost-effective and quality-assured.Fórmula:C23H18Cl2F3NO4SPureza:98% - ≥95%Cor e Forma:SolidPeso molecular:532.36Ref: TM-T7388
1mg52,00€2mg74,00€5mg114,00€1mL*10mM (DMSO)136,00€10mg177,00€25mg358,00€50mg437,00€100mg627,00€200mg898,00€Cintirorgon
CAS:Cintirorgon (LYC-55716) is a selective, oral agonist of RORγ. Cintirorgon modulates gene expression of RORγ expressing T lymphocyte immune cells.Fórmula:C27H23F6NO6SPureza:99.92%Cor e Forma:SolidPeso molecular:603.53Ref: TM-TQ0007
1mg66,00€5mg130,00€1mL*10mM (DMSO)167,00€10mg178,00€25mg313,00€50mg447,00€100mg620,00€SR1001
CAS:SR 1001 is an inverse agonist for RORα/RORγ (Kis: 172/111 nM).Fórmula:C15H13F6N3O4S2Pureza:98.93%Cor e Forma:SolidPeso molecular:477.4GSK2981278
CAS:GSK2981278 (ROR gama modulator 1) is a highly potent and selective inverse agonist of retinoic acid receptor-related orphan receptor gamma (ROR gamma).Fórmula:C25H35NO5SPureza:99.31% - 99.67%Cor e Forma:SolidPeso molecular:461.61RORγt inverse agonist 13
CAS:RORγt inverse agonist 13 (Compound 3i) is a potent, orally active and selective RORγt inverse agonist (IC50=63.8 nM), with improved drug-like properties[1].Fórmula:C23H17Cl2F3N2O4Pureza:99.04%Cor e Forma:SolidPeso molecular:513.29Ref: TM-T9623
1mg50,00€5mg110,00€1mL*10mM (DMSO)124,00€10mg170,00€25mg295,00€50mg420,00€100mg572,00€200mg772,00€S18-000003
CAS:S18-000003: Oral retinoic acid receptor gamma-t inhibitor, IC50 29 nM, reduces IL-17 production.Fórmula:C26H25F3N2O4SPureza:99.24% - 99.31%Cor e Forma:SolidPeso molecular:518.55Ref: TM-T16832
1mg54,00€5mg118,00€1mL*10mM (DMSO)135,00€10mg178,00€25mg318,00€50mg445,00€100mg627,00€500mg1.251,00€SR3335
CAS:SR3335 (ML 176) is a selective inverse agonist of RORα, competitively inhibiting the binding of 25-hydroxycholesterol to the ligand binding domain (Ki: 220 nM).Fórmula:C13H9F6NO3S2Pureza:99.77%Cor e Forma:SolidPeso molecular:405.34Ref: TM-T5160
1mg34,00€5mg74,00€1mL*10mM (DMSO)82,00€10mg119,00€25mg233,00€50mg371,00€100mg595,00€200mg833,00€SR1078
CAS:SR1078 is an agonist of retinoic acid receptor-related orphan receptor (ROR)α/γ.Fórmula:C17H10F9NO2Pureza:99.58%Cor e Forma:SolidPeso molecular:431.25Ref: TM-T4594
1mg39,00€2mg52,00€5mg85,00€1mL*10mM (DMSO)87,00€10mg109,00€25mg215,00€50mg349,00€100mg517,00€T0901317
CAS:T0901317 is a potent and selective agonist for both LXR and FXR, with EC50 of ~50 nM and 5 μM, respectively; it inhibits nuclear factor/κB (NF/κB).Fórmula:C17H12F9NO3SPureza:98% - 99.64%Cor e Forma:SolidPeso molecular:481.33Cedirogant
CAS:Cedirogant (ABBV-157) is an orally active retinoid-related orphan receptor-γt(RORγt) inverse agonist that is used for psoriasis study.Fórmula:C24H20Cl3F3N2O3Pureza:99.20%Cor e Forma:SolidPeso molecular:547.78Ref: TM-T9635
1mg81,00€5mg167,00€1mL*10mM (DMSO)197,00€10mg259,00€25mg470,00€50mg703,00€100mg1.044,00€200mg1.404,00€SR0987
CAS:SR0987 is a RORγt agonist,Fórmula:C16H10ClF6NO2Pureza:99.43%Cor e Forma:SolidPeso molecular:397.7Nobiletin
CAS:Nobiletin: a citrus-derived flavone with anti-inflammatory and anti-cancer properties; water-insoluble, very weak acid.Fórmula:C21H22O8Pureza:98.65% - 99.76%Cor e Forma:SolidPeso molecular:402.39Ref: TM-T2834
5mg54,00€1mL*10mM (DMSO)56,00€10mg84,00€25mg117,00€50mg159,00€100mg251,00€200mg371,00€500mg620,00€TF-S14
CAS:TF-S14 is an inverse agonist of RORγt. It functions by binding to RORγt and inhibiting its activity, leading to a reduction in Th17 cell-associated cytokine production, including IL-17A, IL-21, and IL-22. TF-S14 is applicable in research related to autoimmune diseases and allogeneic transplant rejection.Fórmula:C22H27N3O2SCor e Forma:SolidPeso molecular:397.53XY101
CAS:XY101 is a selective, metabolically stable and orally available agonist of RORγ inverse(IC50 of 30 nM and a Kd of 380 nM).Fórmula:C25H20F7NO4SPureza:99.83%Cor e Forma:SolidPeso molecular:563.48Ref: TM-T13362
1mg82,00€5mg161,00€1mL*10mM (DMSO)193,00€10mg269,00€25mg427,00€50mg610,00€100mg820,00€500mg1.603,00€RORγt Inverse agonist 8
CAS:RORγt Inverse agonist 8 is a potent, selective, orally bioavailable RORγt inverse agonist(human RORγt-LBD with an IC50 of 19 nM).Fórmula:C26H33N7O2Pureza:98%Cor e Forma:SolidPeso molecular:475.59GNE-0946
CAS:GNE-0946 is an effective and selective RORγ/RORc/NR1F3 antagonist (inverse agonist) with an EC50 of 4 nM in HEK-293 cells. autoimmune disease research.Fórmula:C22H12ClF3N2O4Pureza:98.11%Cor e Forma:SolidPeso molecular:460.79MRL-871
CAS:MRL-871 is a selective RORγt allosteric inhibitor, reducing IL-17a mRNA production in EL4 cells, interacting with PPARgamma in partial agonistic binding modes.Fórmula:C22H12ClF3N2O3Pureza:99.66%Cor e Forma:SolidPeso molecular:444.79Ref: TM-T62622
1mg90,00€5mg215,00€1mL*10mM (DMSO)236,00€10mg356,00€25mg715,00€50mg1.153,00€100mg1.783,00€200mg2.412,00€Methyl-3β-hydroxycholenate
CAS:Methyl-3β-hydroxycholenate (Methyl 3beta-hydroxychol-5-enoate) is a modulator of RORγ.Fórmula:C25H40O3Pureza:98.78%Cor e Forma:SolidPeso molecular:388.58AZD-0284
CAS:AZD-0284 is an inverse agonist of the nuclear receptor RORγ. In development for the treatment of plaque psoriasis vulgaris and respiratory tract disorders[1].Fórmula:C21H18F6N2O5SPureza:99.82%Cor e Forma:SolidPeso molecular:524.43ML 209
CAS:ML-209 is an antagonist of retinoic acid receptor-related orphan receptor γt (RORγt; IC50= 1.1 μM in a reporter assay).1It inhibits RORγt-induced transcriptionFórmula:C25H31NO6Pureza:99.87%Cor e Forma:SolidPeso molecular:441.52SR2211
CAS:SR2211 is a specific modulator and an inverse agonist of RORγ(IC50 = 320 nM, Ki = 105 nM).Fórmula:C26H24F7N3OPureza:98.75%Cor e Forma:SolidPeso molecular:527.48Ref: TM-T16929
1mg49,00€5mg90,00€1mL*10mM (DMSO)114,00€10mg170,00€25mg260,00€50mg356,00€100mg505,00€500mg1.071,00€RORγt inverse agonist 14
CAS:RORγt inverse agonist 14 (8e) is a potent, selective, and orally active compound with an EC50 of 2.5 nM, exhibiting anti-inflammatory activity.Fórmula:C26H26F8N2O6S2Pureza:98%Cor e Forma:SolidPeso molecular:678.613-Oxo-5β-cholanoic acid
CAS:3-Oxo-5β-cholanoic acid (Dehydrolithocholic acid) (Dehydrolithocholic acid) is a bile acid metabolite and inhibits the differentiation of TH17 cells by directlyFórmula:C24H38O3Pureza:98.01% - 99.86%Cor e Forma:SolidPeso molecular:374.56TMP780
CAS:TMP780 is an inverse RORγt agonist (IC50: 13 nM). RORγt is a tractable drug target for the treatment of cutaneous inflammatory disorders.Fórmula:C31H30N2O4Pureza:98%Cor e Forma:SolidPeso molecular:494.58RORγt Inverse agonist 6
CAS:RORγt Inverse agonist 6 is an agonist of RORγt inverse. RORγt Inverse agonist 6 can be used in research on Th17-driven autoimmune diseases.Fórmula:C28H29ClN6O5Pureza:99.52%Cor e Forma:SolidPeso molecular:565.02Ref: TM-T12753
1mg58,00€5mg133,00€1mL*10mM (DMSO)165,00€10mg190,00€25mg306,00€50mg414,00€100mg532,00€200mg705,00€FM26
CAS:FM26, an isoxazole-based RORγt inverse agonist, cuts EL4 IL-17a mRNA; potent with 264 nM IC50.Fórmula:C22H15ClF3N3O3Pureza:98%Cor e Forma:SolidPeso molecular:461.82JTE-151
CAS:JTE-151, a RORγ inhibitor, suppresses the overactive immune response by inhibiting RORγ, which is linked to the activation of Th17 cells. This action positions JTE-151 as a potential candidate for autoimmune disease research [1].Fórmula:C28H37ClN2O4Peso molecular:501.06RORγt inverse agonist 34
CAS:RORγt inverse agonist 34 (compound 5a) is an inverse agonist for RORγt, exhibiting an IC50 of 0.094 μM for the inhibition of RORγt-LBD. This compound is utilized in psoriasis research.Fórmula:C31H37N3O3SCor e Forma:SolidPeso molecular:531.709RORγ-IN-2
CAS:RORγ-IN-2 (Compound 22) is an inhibitor of RORγ, with a Ki value of 16.6 nM for hRORγ. It is useful for research in IL-17-dependent autoimmune diseases.
Fórmula:C28H32F3N5O4S2Cor e Forma:SolidPeso molecular:623.71RORγt inverse agonist 32
CAS:RORγt inverse agonist 32 (compound b14) exhibits oral activity and can be utilized in inflammatory research studies.Fórmula:C24H28F3NO5SCor e Forma:SolidPeso molecular:499.54TAK-828F
CAS:TAK-828F: potent, selective RORγt inverse agonist. Oral. IC50=1.9 nM; reporter gene IC50=6.1 nM.Fórmula:C28H32FN3O5Pureza:98%Cor e Forma:SolidPeso molecular:509.57RORγt inhibitor 4
CAS:RORγt inhibitor 4 (Compound 9a) is an orally active RORγt inhibitor capable of penetrating the central nervous system. It has been shown to improve experimental autoimmune encephalomyelitis.Fórmula:C22H16Cl2F3NO4SCor e Forma:SolidPeso molecular:518.333ROR1-IN-1
CAS:ROR1-IN-1 (Compound 19h) is an inhibitor of receptor tyrosine kinase-like orphan receptor 1 (ROR1) with a Ki of 0.10 μM. It inhibits the proliferation of cancer cell lines H1975, A549, and MDA-MB-231, with IC50 values of 0.36 μM, 1.37 μM, and 0.47 μM, respectively. In mice, ROR1-IN-1 demonstrates antitumor efficacy and exhibits favorable pharmacokinetic properties in a rat model.Fórmula:C33H27N5O3Peso molecular:541.60Vimirogant
CAS:Vimirogant is a RORγ inhibitor (Ki: <100 nM).Fórmula:C27H35F3N4O3SPureza:98%Cor e Forma:SolidPeso molecular:552.65
